CRIS Current Research Information System

TADOLINI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.749
AS - Asia 3.407
EU - Europa 2.419
SA - Sud America 269
AF - Africa 241
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.696
SG - Singapore 1.118
CN - Cina 1.003
GB - Regno Unito 797
VN - Vietnam 488
SE - Svezia 387
DE - Germania 301
HK - Hong Kong 269
IT - Italia 239
BR - Brasile 198
KR - Corea 189
RU - Federazione Russa 172
IN - India 168
FR - Francia 106
IE - Irlanda 90
CI - Costa d'Avorio 68
NL - Olanda 67
FI - Finlandia 58
ZA - Sudafrica 57
SC - Seychelles 56
EE - Estonia 43
UA - Ucraina 39
AR - Argentina 36
ID - Indonesia 33
TG - Togo 32
CA - Canada 28
JP - Giappone 28
CH - Svizzera 21
AT - Austria 20
JO - Giordania 16
MX - Messico 16
TW - Taiwan 16
BE - Belgio 15
BG - Bulgaria 14
AU - Australia 12
EC - Ecuador 12
PL - Polonia 12
PK - Pakistan 11
GR - Grecia 10
PH - Filippine 10
BD - Bangladesh 9
TR - Turchia 9
MA - Marocco 7
MY - Malesia 7
NG - Nigeria 7
ES - Italia 6
TH - Thailandia 6
IQ - Iraq 5
LT - Lituania 5
PY - Paraguay 5
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
ET - Etiopia 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
IR - Iran 3
RO - Romania 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
IL - Israele 2
LB - Libano 2
LS - Lesotho 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CD - Congo 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.101
Salva come PNG Salva come JPEG
Città #
Southend 745
Singapore 735
Ashburn 463
Fairfield 378
Hefei 377
Santa Clara 300
Hong Kong 267
Chandler 208
Wilmington 186
Seoul 185
Houston 180
Woodbridge 177
Seattle 171
Cambridge 147
Ho Chi Minh City 136
Beijing 129
Princeton 128
Ann Arbor 117
Boardman 100
Hanoi 100
Dallas 96
Dublin 90
Dong Ket 88
Bologna 69
Abidjan 68
New York 58
Nanjing 56
Los Angeles 47
Westminster 46
Buffalo 42
Helsinki 41
Padova 40
Bengaluru 39
Frankfurt am Main 37
Dearborn 35
Lomé 32
San Diego 32
Saint Petersburg 30
Berlin 27
Milan 26
Nuremberg 26
Redondo Beach 26
Tokyo 26
Jakarta 22
Bern 19
São Paulo 17
Amman 16
Nanchang 16
Falls Church 15
Brussels 14
Des Moines 14
Hebei 14
Sofia 14
Tongling 14
Changsha 13
Jinan 13
Shenyang 13
Toronto 13
Yubileyny 13
Bremen 12
Da Nang 12
Haiphong 12
Falkenstein 11
Lappeenranta 11
Moscow 11
Munich 11
Redwood City 11
Zhengzhou 11
Washington 10
Amsterdam 9
Guangzhou 9
London 9
Shanghai 9
Biên Hòa 8
Hải Dương 8
Jiaxing 8
Quận Bình Thạnh 8
Redmond 8
San Francisco 8
San Jose 8
Tianjin 8
Vienna 8
Campinas 7
Chicago 7
Council Bluffs 7
Harbin 7
Jacksonville 7
Johannesburg 7
Kunming 7
Norwalk 7
Turin 7
Warsaw 7
Atlanta 6
Bangkok 6
Boston 6
Chengdu 6
Chennai 6
Medford 6
Paris 6
Phoenix 6
Totale 6.884
Salva come PNG Salva come JPEG
Nome #
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 395
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 209
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 204
TB consilia and quality of tuberculosis management 173
First evaluation of QuantiFERON-TB gold plus performance in contact screening 171
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF 163
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review 159
A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European respiratory society-World Health Organization tuberculosis consilium 155
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 152
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 148
Tuberculosis elimination: Theory and practice in Europe 148
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 147
Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay 147
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 146
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 145
Combined use of delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis: A systematic review 145
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 145
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 144
Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings 141
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe 140
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: Early experiences and challenges 140
Overview of fever of unknown origin in adult and paediatric patients 139
Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs 139
The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011 134
Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases 134
Systematic Tuberculosis Screening in Asylum Seekers in Italy 133
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine 132
The International Journal of Tuberculosis and Lung Disease (IJTLD) 130
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis 130
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy 130
Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study 129
Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis 129
IGRA test for TB in COVID-19: role of corticosteroids 127
Compassionate and optimum use of new tuberculosis drugs 125
Update of drug-resistant tuberculosis treatment guidelines: A turning point 124
Clinical standards for drug-susceptible pulmonary TB 124
Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: A systematic review 124
Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019 123
Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis 123
World Tuberculosis Day 2023 theme “Yes! We Can End TB!” 122
Clinical standards for the management of adverse effects during treatment for TB 122
First independent evaluation of QuantiFERON-TB Plus performance 121
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. 119
Recommendations for the diagnosis of pediatric tuberculosis 119
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 118
New and repurposed drugs for pediatric multidrug-resistant tuberculosis practice-based recommendations 117
Recommendations for treating children with drug-resistant tuberculosis 117
Clinical standards for the dosing and management of TB drugs 116
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 114
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort 113
WHO strategies for the programmatic management of drug-resistant tuberculosis 111
Paediatric tuberculosis in Europe: Lessons from Denmark and inclusive strategies to consider 111
ERS/WHO Tuberculosis Consilium: Reporting of the initial 10 cases 110
Supporting clinical management of the difficult-to-treat TB cases: The ERS-WHO TB Consilium 109
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline 109
Quantiferon-TB performs better in children, including infants, than in adults with active tuberculosis: a multicentre study 109
Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017–2019 108
Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey 107
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use 107
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians 106
Recommendations Concerning the Therapeutic Approach to Immunocompromised Children with Tuberculosis 105
Faster for less: The new "shorter" regimen for multidrug-resistant tuberculosis 104
Seventeen cases of Mycobacterium marinum infection in Italy: A multicenter retrospective study 102
Recommendations Concerning the First-Line Treatment of Children with Tuberculosis 101
Vaccination in post-tuberculosis lung disease management: A review of the evidence 98
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort 95
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study 94
Introduction of bedaquiline for the treatment of multi-drug resistant tuberculosis at country level: implementation plan 89
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts 85
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report 82
On tuberculosis and COVID-19 co-infection 80
A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: The ERS-WHO TB consilium 75
National population-based tuberculosis prevalence survey in Ghana, 2013 75
National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned 73
TB mortality in low-incidence countries: can we reduce it further? 69
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020 68
null 64
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study 62
Reducing tuberculosis transmission: A consensus document from the World Health Organization Regional Office for Europe 58
null 57
Gauging the impact of the COVID-19 pandemic on tuberculosis services: A global study 57
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 57
COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom 53
High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey 48
National TB prevalence surveys in the COVID-19 era 46
We cannot eliminate TB without TB drugs: a wake-up call from Italy 40
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond 40
Ten common myths about drug-susceptible TB 39
TB outpatient care in a high-income, low-incidence country 39
Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature 38
Consolidated guidance on tuberculosis data generation and use. Module 3. National tuberculosis prevalence surveys. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO 24
Totale 10.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021506 0 0 0 0 0 0 23 51 115 58 42 217
2021/20221.145 69 72 79 116 109 54 28 79 30 101 210 198
2022/20231.111 84 134 66 137 104 100 42 63 234 19 77 51
2023/2024470 30 62 37 50 53 108 14 21 31 36 16 12
2024/20252.082 36 272 122 120 407 119 131 60 23 109 143 540
2025/20262.769 474 589 557 375 498 275 1 0 0 0 0 0
Totale 10.348